Fruzaqla (Fruquintinib)

Fruzaqla (fruquintinib) is a kinase inhibitor indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.

Recommended Dosage:
The recommended dose of Fruzaqla is 5 mg orally once daily for the first 21 days of each 28-day cycle until there is evidence of disease progression or unacceptable toxicity. Take this medicine with or without food at approximately the same time each day. Swallow the capsules whole.

Take a missed dose if less than 12 hours have passed since the missed scheduled dose. Do not take two doses on the same day to make up for a missed dose. Do not take an additional dose if vomiting occurs after taking Fruzaqla, but continue with the next scheduled dose.

• Treatment with Fruzaqla may increase blood pressure during treatment. Patients should have their blood pressure checked regularly. If it becomes too high, your clinician may adjust the dose or start medicine to control it. Report symptoms like headaches, dizziness, or vision changes promptly.
• This medicine may increase the risk of bleeding, including serious cases. Patients should inform their doctor if they notice unusual bruising, nosebleeds, or blood in urine or stool. Avoid activities that increase injury risk and use caution with medications that affect bleeding.
• Treatment with this drug may make it easier to develop infections. Patients should watch for signs like fever, chills, cough, or sore throat. It is important to maintain hygiene and report symptoms early so treatment can be started promptly if needed.
• In rare cases, Fruzaqla may cause a hole in the stomach or intestine. Symptoms include severe abdominal pain, vomiting, or fever. This is a serious condition and requires immediate medical attention. Contact your doctor right away if these symptoms occur.
• Fruzaqla can affect liver function. Doctors may perform regular blood tests to monitor liver enzymes. Symptoms such as yellowing of the skin or eyes, dark urine, or unusual fatigue should be reported immediately, as they may indicate liver-related side effects.
• Palmar-Plantar Erythrodysesthesia (PPE), also known as hand-foot syndrome, this condition can cause redness, swelling, or pain on the palms and soles. Patients should keep skin moisturized, avoid heat and friction, and inform their doctor if symptoms worsen or interfere with daily activities.
• Fruzaqla may slow down the healing of wounds. It is important to inform your doctor if you have surgery planned or recent injuries. Treatment may need to be paused before and after surgical procedures to reduce the risk of complications.
• This medicine may increase the risk of blood clots in arteries, which can lead to serious conditions like a heart attack or stroke. Patients should seek immediate medical help if they experience chest pain, weakness, difficulty speaking, or sudden vision changes.
• Fruzaqla may harm an unborn baby. Women who are pregnant or planning to become pregnant should not use this medicine. Effective contraception should be used during treatment and for a period after stopping the drug, as advised by the doctor.
• It is not known if Fruzaqla passes into breast milk, but it may pose a risk to the baby. Breastfeeding is not recommended during treatment and for some time after the last dose. Patients should consult their doctor for guidance.

What documents are required to import FRUZAQLA to India?

FRUZAQLA (fruquintinib) capsules may be imported by patients or government hospitals in the patients’ names only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is FRUZAQLA available in India?

FRUZAQLA (fruquintinib capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) facilitates the import of cancer medicines under named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Fruzaqla in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Fruzaqla price in India.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

FRUZAQLA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of FRUZAQLA (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact us at WhatsApp: +91 98104 69557 | Toll-Free Number: 1800-1200-365 or write us at info@indianpharmanetwork.in for Fruzaqla cost in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source FRUZAQLA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Fruzaqla®?

Fruquintinib is the Generic Name for the trade name drug Fruzaqla®.

What is the Manufacturer’s Name of Fruzaqla®?

Fruzaqla® is manufactured by Takeda Pharma Co., Ltd.

Is Fruzaqla® approved by the FDA?

Yes. Fruzaqla® is approved by the FDA. Date of first approval: November 8, 2023.

What strengths and dosage forms are available for Fruzaqla®?

Fruzaqla® is available as Capsules: 1 mg and 5 mg for oral administration.

What are the most common side effects of Fruzaqla® Capsules?

The most commonly reported side effects of Fruzaqla are hypertension, abdominal pain, palmar-plantar erythrodysesthesia, proteinuria, dysphonia, diarrhea, and asthenia.

What is the availability of Fruzaqla near Medanta Hospital in Gurgaon?

Patients receiving treatment near Medanta Hospital can buy Fruzaqla through a patient-specific import pathway. With a valid oncologist’s prescription, the treatment can be arranged and delivered directly to the hospital in Gurgaon.

What is the availability of Fruzaqla in Bangalore?

Fruzaqla in Bangalore is not yet commercially marketed, but patients can still access it through regulated import provisions. Once prescribed by a treating clinician, the medicine is sourced internationally and supplied to the treating hospital.

Is Fruzaqla available at HCG Cancer Centre, Bangalore?

Fruzaqla may not be routinely stocked in India. However, it can be accessed through a Named Patient Program (NPP) with a valid prescription from an oncologist at the hospital. Indian Pharma Network (IPN) can help facilitate the import of Fruzaqla at HCG Cancer Centre, Bangalore.

What is the availability of Fruzaqla in Mumbai?

Patient can buy Fruzaqla in Mumbai via special access programs that allow import of approved international medicines. The treatment is delivered to the hospital where the patient is undergoing care.

I want to buy Fruzaqla in Mumbai. How can I access it?

If you are looking to buy Fruzaqla in Mumbai, the first step is consultation with your oncologist. Once prescribed, the medicine can be sourced from global suppliers through a compliant import process and delivered to your treating hospital.

What is the availability of Fruzaqla in Chennai?

Patient access to Fruzaqla in Chennai is possible through special access programs such as Named Patient Programs (NPP), which allow the import of internationally approved medicines. The treatment is arranged and delivered directly to the hospital where the patient is receiving care, ensuring compliance with regulatory requirements.

I want to buy Fruzaqla in Chennai. How can I access it?

If you are looking to access Fruzaqla in Chennai, the first step is to consult your oncologist. Upon prescription, the medicine can be sourced from global suppliers through a compliant import process under NPP and delivered to your treating hospital, such as Apollo Hospitals Chennai or Cancer Institute (WIA).

What is the availability of Fruzaqla in Hyderabad?

Fruzaqla is accessible in Hyderabad through special access programs like Named Patient Programs (NPP), which enable the legal import of medicines not widely available in India. The medication is delivered directly to the hospital where the patient is undergoing treatment.

I want to buy Fruzaqla in Hyderabad. How can I access it?

To access Fruzaqla in Hyderabad, patients should first consult their oncologist. Once prescribed, the medicine can be arranged through authorized channels under NPP guidelines and delivered to the treating hospital, such as Basavatarakam Indo-American Cancer Hospital.

I want to buy Fruzaqla in Bangalore. How can I access it?

Patients seeking access to Fruzaqla in Bangalore should consult their oncologist for evaluation and prescription. Following this, the medicine can be procured through compliant import channels and delivered to the treating hospital, such as HCG Cancer Centre Bangalore.

Can I buy Fruzaqla at major hospitals like Tata, HCG Cancer Centre, Apollo, or Fortis?

Fruzaqla can be accessed at leading hospitals such as Tata Memorial Centre, HCG Cancer Centre, Basavatarakam Indo-American Cancer Hospital, Cancer Institute (WIA), Apollo Hospitals, Fortis Healthcare, Max Healthcare, Rajiv Gandhi Cancer Institute & Research Centre, Manipal Hospitals, and Kokilaben Dhirubhai Ambani Hospital through the Named Patient Program (NPP) with a valid oncologist’s prescription. Indian Pharma Network assists with import and delivery to the treating hospital.

How does Fruzaqla Import in India work?

Fruzaqla Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

Who is a reliable Fruzaqla supplier in India?

Indian Pharma Network is a trusted Fruzaqla supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.

How much does Fruzaqla cost in India?

Fruzaqla is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Fruzaqla prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Fruzaqla cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Fruzaqla be available in SAARC countries?

Apart from Gulf countries, Fruzaqla can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Fruzaqla in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Fruzaqla online in India?

Yes, one can buy Fruzaqla in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Fruzaqla through legal channels.

Who is an authorized Fruzaqla importer in India?

Indian Pharma Network acts as the Fruzaqla importer in India, assisting with Named Patient Import processes, regulatory documentation, and compliant international procurement for patients requiring this therapy.

In which countries is Fruzaqla approved?

Fruzaqla (fruquintinib) has been approved in the United States, the European Union, Japan, Canada, China, and Switzerland for the treatment of advanced/metastatic colorectal cancer.

Can I buy Fruzaqla from Europe, the USA, or other countries?

As of now, Fruzaqla is approved and available in the United States, the European Union, Japan, Canada, China, and Switzerland, but patients in India cannot directly purchase it from abroad. It can be legally accessed through the Named Patient Program (NPP) with a valid prescription. Indian Pharma Network assists with compliant sourcing and delivery to the treating hospital.

What are the storage conditions of Fruzaqla® Capsules?

Store the capsules of Fruzaqla at 20°C to 25°C (68°F to 77°F). Brief exposure to 15°C and 30°C (59°F to 86°F).